Qingqing Wu
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction.
Journal: Circulation
Published: January 06, 2026
OTUD7a Accelerates Pathological Cardiac Hypertrophy via TAK1 Activation.
Journal: Circulation research
Published: November 21, 2025
PCI for Chronic Total Occlusions with Distal Diffuse Disease: Stent Alone vs. Stent plus Drug Balloon.
Journal: International journal of cardiology. Heart & vasculature
Published: April 22, 2025
The Role of HINT3 in Myocardial Ischemia-Reperfusion Injury in Male Mice: Mechanisms Involving SDHA and its Acetylation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 18, 2025
(Apo)Lipoprotein Profiling with Multi-Omics Analysis Identified Medium-HDL-Targeting PSRC1 with Therapeutic Potential for Coronary Artery Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 23, 2024
Fucoxanthin alleviated atherosclerosis by regulating PI3K/AKT and TLR4/NFκB mediated pyroptosis in endothelial cells.
Journal: International immunopharmacology
Published: February 23, 2023
Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2.
Journal: Cell reports. Medicine
Published: January 19, 2023
OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling.
Journal: Journal of translational medicine
Published: December 10, 2022
Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling.
Journal: EBioMedicine
Published: August 04, 2022
Long non-coding RNA Pvt1 modulates the pathological cardiac hypertrophy via miR-196b-mediated OSMR regulation.
Journal: Cellular signalling
Published: February 09, 2021
Inhibition of 5-lipoxygenase is associated with downregulation of the leukotriene B4 receptor 1/ Interleukin-12p35 pathway and ameliorates sepsis-induced myocardial injury.
Journal: Free radical biology & medicine
Published: December 20, 2020
S100A8/A9 in Myocardial Infarction: A Promising Biomarker and Therapeutic Target.
Journal: Frontiers in cell and developmental biology
Published: September 08, 2020
Last Updated: 09/26/2026